Delivery Order SPE2DB20D7066-SPE2DB25FC1ZG
Award Date
1/7/25
Potential Completion Date
1/8/25
Potential Value
$10K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the supply of Humira (adalimumab) 40 mg/0.4 mL prefilled pens, a specialty medication used to treat various autoimmune conditions. The contract has a ceiling value of $18,849.72 and a period of performance through September 22, 2022. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Humira (adalimumab) Pen 40 mg/0.4 mL. The contract has a firm fixed price of $16,552.17 and a completion date of September 11, 2024. This delivery order is part of a larger Indefinite Delivery Contract between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025,...
This federal contract award, valued at $2,770.74, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Humira (adalimumab) Pen 40 mg/0.4 mL, a specialty medication.
The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 24, 2024. It is not designated as a set-aside contract. Amerisourcebergen holds a larger Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The order is for the supply of Humira (adalimumab) 40 mg/0.4 mL auto-injector pens, a specialty medication used to treat various autoimmune conditions. The contract has a firm fixed price of $2,770.74 and a period of performance through August 29, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999...
This federal contract award, valued at $23,148.20, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the delivery of Humira (Adalimumab) 40 mg/0.4 mL prefilled pens, a specialty medication used to treat various autoimmune conditions.
The contract is a Firm Fixed Price Delivery Order with a period of performance through November 2024. It is not designated as a set-aside...
This federal contract award, valued at $90,654.13, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November 2026.
The contract covers the supply of ADALIMUMAB 2PPN 2S, a pharmaceutical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation and a for-profit organization. The contract is for the delivery of Adalimumab, a pharmaceutical product, with a potential value of $5,079.69 and a completion date of February 20, 2024. The contract is a firm fixed price delivery order and does not have a set-aside designation.
Amerisourcebergen Drug Corp is the...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Humira (adalimumab) 40 mg/0.4 mL pens, a specialty medication used to treat various autoimmune conditions. The contract has a ceiling value of $8,932.92 and a period of performance through March 22, 2022.
Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc. Both entities are...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $9,622.88 firm fixed-price contract is for the supply of Humira (adalimumab) 40 mg/0.4 mL syringes, a biologic medication used to treat various autoimmune conditions. This contract is a delivery order under AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a broad range of...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $126,158.40 contract is for the supply of adalimumab, a pharmaceutical product, to support military treatment programs and facilities. The contract has a performance period ending on October 6, 2017 and does not have a set-aside designation. Amerisourcebergen Drug Corp has a history of providing...